Molecular Updates in Prostate Cancer

George J. Netto

Research output: Contribution to journalReview article

Abstract

A wide array of molecular markers and genomic signatures, reviewed in this article, may soon be used as adjuncts to currently established screening strategies, prognostic parameters, and early detection markers. Markers of genetic susceptibility to PCA, recurrent epigenetic and genetic alterations, including ETS gene fusions, PTEN alterations, and urine-based early detection marker PCA3, are discussed. Impact of recent genome-wide assessment on our understanding of key pathways of PCA development and progression and their potential clinical implications are highlighted.

Original languageEnglish (US)
Pages (from-to)561-580
Number of pages20
JournalSurgical Pathology Clinics
Volume8
Issue number4
DOIs
StatePublished - 2015

Fingerprint

Passive Cutaneous Anaphylaxis
Prostatic Neoplasms
Gene Fusion
Genetic Predisposition to Disease
Epigenomics
Urine
Genome

Keywords

  • Carcinogenesis
  • Genomic classification
  • PCA3
  • Prostate cancer

ASJC Scopus subject areas

  • Surgery
  • Pathology and Forensic Medicine

Cite this

Molecular Updates in Prostate Cancer. / Netto, George J.

In: Surgical Pathology Clinics, Vol. 8, No. 4, 2015, p. 561-580.

Research output: Contribution to journalReview article

Netto, George J. / Molecular Updates in Prostate Cancer. In: Surgical Pathology Clinics. 2015 ; Vol. 8, No. 4. pp. 561-580.
@article{6548ac3da3974380aae12b999a5b6f81,
title = "Molecular Updates in Prostate Cancer",
abstract = "A wide array of molecular markers and genomic signatures, reviewed in this article, may soon be used as adjuncts to currently established screening strategies, prognostic parameters, and early detection markers. Markers of genetic susceptibility to PCA, recurrent epigenetic and genetic alterations, including ETS gene fusions, PTEN alterations, and urine-based early detection marker PCA3, are discussed. Impact of recent genome-wide assessment on our understanding of key pathways of PCA development and progression and their potential clinical implications are highlighted.",
keywords = "Carcinogenesis, Genomic classification, PCA3, Prostate cancer",
author = "Netto, {George J.}",
year = "2015",
doi = "10.1016/j.path.2015.08.003",
language = "English (US)",
volume = "8",
pages = "561--580",
journal = "Surgical Pathology Clinics",
issn = "1875-9181",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Molecular Updates in Prostate Cancer

AU - Netto, George J.

PY - 2015

Y1 - 2015

N2 - A wide array of molecular markers and genomic signatures, reviewed in this article, may soon be used as adjuncts to currently established screening strategies, prognostic parameters, and early detection markers. Markers of genetic susceptibility to PCA, recurrent epigenetic and genetic alterations, including ETS gene fusions, PTEN alterations, and urine-based early detection marker PCA3, are discussed. Impact of recent genome-wide assessment on our understanding of key pathways of PCA development and progression and their potential clinical implications are highlighted.

AB - A wide array of molecular markers and genomic signatures, reviewed in this article, may soon be used as adjuncts to currently established screening strategies, prognostic parameters, and early detection markers. Markers of genetic susceptibility to PCA, recurrent epigenetic and genetic alterations, including ETS gene fusions, PTEN alterations, and urine-based early detection marker PCA3, are discussed. Impact of recent genome-wide assessment on our understanding of key pathways of PCA development and progression and their potential clinical implications are highlighted.

KW - Carcinogenesis

KW - Genomic classification

KW - PCA3

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84951806530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951806530&partnerID=8YFLogxK

U2 - 10.1016/j.path.2015.08.003

DO - 10.1016/j.path.2015.08.003

M3 - Review article

VL - 8

SP - 561

EP - 580

JO - Surgical Pathology Clinics

JF - Surgical Pathology Clinics

SN - 1875-9181

IS - 4

ER -